Brief: Coherus BioSciences Q3 Operating Income USD -6.387 Million Vs. IBES Estimate USD -13.3 Million
06/11/2024 21:01
Nov 06 (Reuters) - Coherus BioSciences Q3 net income USD -10.751 million. * Q3 pretax profit USD -10.751 million vs. IBES estimate USD -18.6 million * Q3 sales USD 70.774 million vs. IBES estimate USD 59.2 million * Q3 adjusted net income USD -1.7 million vs. IBES estimate USD -12.1 million
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million